Biosynth’s unique online custom peptide toolset completed with full order tracking and QC data portal

FHS
June 28, 2024
4:41 pm

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution.

Agios sells vorasidenib US royalties for $905m – Pharmaceutical Technology

Caption: Royalty Pharma projects more than $1bn in annual peak sales for vorasidenib. Image credit: Shutterstock/ ADragan. As Servier’s day of reckoning with US Food

May 30, 2024

Democrat lawmakers call on FDA to take steps to prevent misuse of Orange Book

Sen. Elizabeth Warren (D-MA) and Rep. Pramila Jayapal (D-WA) are calling on the FDA to make reforms to the Orange Book of generic drug patents

August 31, 2023

Could better inhalers help patients, and the planet?

Miguel Divo, a lung specialist at Brigham and Women’s Hospital in Boston, sits in an exam room across from Joel Rubinstein, who has asthma. Rubinstein,

May 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.